Oxygen-exacerbated bleomycin pulmonary toxicity

Mayo Clin Proc. 1991 Feb;66(2):173-8. doi: 10.1016/s0025-6196(12)60489-3.

Abstract

Bleomycin is an antineoplastic agent with potential for producing pulmonary toxicity, attributed in part to its free radical-promoting ability. Clinical and research experiences have suggested that the risk of bleomycin-induced pulmonary injury is increased with the administration of oxygen. We report a case in which the intraoperative administration of oxygen in the setting of previous bleomycin therapy contributed to postoperative ventilatory failure. Our patient recovered with corticosteroid therapy. Physician awareness of a potential interaction between oxygen and bleomycin may help reduce the morbidity and mortality related to bleomycin therapy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acute Disease
  • Adult
  • Bleomycin / adverse effects*
  • Drug Synergism
  • Humans
  • Intraoperative Care
  • Lung Neoplasms / drug therapy*
  • Male
  • Neoplasm Recurrence, Local / surgery
  • Neoplasms, Germ Cell and Embryonal / drug therapy*
  • Oxygen Inhalation Therapy / adverse effects*
  • Reoperation
  • Respiratory Distress Syndrome / chemically induced*

Substances

  • Bleomycin